News

oncNGS PCP - European Call for tender for the future Next Generation Sequencing (NGS) solutions for cancer

Published on | 4 years ago

Programmes
Health

The aim of the oncNGS pre-commercial procurement (PCP) is to develop affordable integrated solutions that can completely transform cancer patients' experience through predictive diagnosis, prognosis and theranosis capabilities based on Next Generation Sequencing (NGS) technology. OncNGS invites entrepreneurs, start-ups, companies, academia, and other relevant stakeholders to present their proposal for designing, developing and testing their solution that will be provided during this PCP.

The oncNGS PCP Call for tender is now open. Deadline for submission is 17 October 2022.

  • The contract notice of the Pre-commercial procurement has been published at Tenders Electronic Daily here.
  • The complete tender documentation is available here.
  • Bidders can participate in a joint tender and look for suitable partners through oncNGS' matchmaking page.
  • A Frequently Asked Questions page is also available on the oncNGS website.

All detailed information can be found on oncNGS' website.

 

Background information: The Horizon 2020 financed project 'OncNGS'  is a strong consortium composed of 8 buyers from 5 EU Member States (Sciensano ; Institut Jules Bordet (Belgium) ; Institut Curie ; Hospices Civils de Lyon (France) ; Charite Universitaetsmedizin ; Ludwig Maximilians Universitaet Muenchen (Germany) ; Alleanza Contro il Cancro (Italy) ; Institut Catala d’Oncologia (Spain)) and supported by 6 entities with wide experience in their fields (Agència de Qualitat i Avaluació Sanitàries de Catalunya ; the Belgian Cancer Registry ; Institut National du Cancer ; Instituto de Investigación Biomédica de Salamanca ; Valle de Hebrón Instituto de Oncología ; De Clercq & Partners). 

 

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1996 articles available search in articles 

Testimonial

image of Theresa PCP: ZAS participates in research developing an on-site system to decontaminate hospital wastewater

Theresa PCP: ZAS participates in research developing an on-site system to decontaminate hospital wastewater

Funded under Horizon Europe (HORIZON-HLTH-2024-CARE-14-01), running from 2025 to 2029, the THERESA PCP aims to launch a pre-commercial procurement process (PCP) based on the development of an environmentally sustainable on-site system to decontaminate hospital wastewater. Ziekenhuis aan de Stroom (ZAS) plays an important role in the project by contributing real-world insights from a large and diverse hospital network. Read more about the project in this testimonial.